An inverse association between 25(OH)D3 levels and the EPO resistance index was observed in HD patients [24], and the administration of vitamin D or its analogs has been associated with improved anemia and/or reduced EPO requirements [25–26]. This evidence concerns the gene EPO and Huntington disease.